Cilostazol tablet

General Name: cilostazol

Chemical Name: 6-[4-(1-cyclohexyl -1H-tetrazole -5-sulfuryl )butoxy ]-3,4-dihydro -2(1H)-quinolone

Structural Formula:

Molecular Formula : C₂₀H₂₇N₅O₂

Molecular Weight : 369.47

Properties : white crystal or powder, slightly soluble in carbinol and ethanol,
insoluble in water

Pharmacological Action: Cilostazol can restrain the activity of blood platelet and phosphodiesterase in smooth muscle; can resist blood platelet 's aggregation and hemangiectasis ; can hold back blood platelet 's aggregation caused by TXA2, but has no effect to the metabolism of arachidonic acid in blood platelet ; can control the blood platelet's conglomeration caused by blood platelet conglomeration inductor ; can reduce the concentration of plasma -thrombus globulin , blood platelet 4th rhesus factor (PF-4); Can dissociate the aggregation block.

Cilostazol is a new medicine for treating steady discontinuous cripple.

Cilostazol quinoline is a type of PDEIII depressor manufactured by American Otsuka Corporation. It is mainly used to treat steady intermittent claudication.

Pharmacological action:
Cilostazol is quinoline derivations, which can control the PDEIII in cells and treat steady discontinuous cripple. Cilostazol and its metabolic products are CAMP-PDEIII depressor, can control PDEIII 's activity and hold back CAMP degradation and transform in blood tablets and blood vessels.

Packing : 25kg/Barrel

cas# : 76963-72-1